Unity Biotechnology, Inc. (UBX)

NASDAQ: UBX · IEX Real-Time Price · USD

1.310

-0.020 (-1.50%)

At close: Jul 2, 2024, 4:00 PM

1.340

+0.030 (2.29%)

After-hours: Jul 2, 2024, 7:08 PM EDT

Unity Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-39.86	-44.47	-60.73	-93.84	-82.18	Upgrade
Depreciation & Amortization	1.18	2.18	2.88	3.45	2.66	Upgrade
Share-Based Compensation	7.42	9.38	11.55	13.81	10.85	Upgrade
Other Operating Activities	-5.83	-19.5	1.23	-1.75	-3.76	Upgrade
Operating Cash Flow	-37.09	-52.41	-45.06	-78.33	-72.42	Upgrade
Capital Expenditures	0.1	0.28	-0.2	-0.65	-1.59	Upgrade
Change in Investments	60.39	-24.83	39.51	-4.56	69.54	Upgrade
Investing Cash Flow	60.5	-24.55	39.31	-5.21	67.95	Upgrade
Share Issuance / Repurchase	5.22	58.21	20.7	39.36	27.51	Upgrade
Debt Issued / Paid	-21.56	0	0.14	24.52	-0.07	Upgrade
Other Financing Activities	-	-1.97	-	-	-	Upgrade
Financing Cash Flow	-16.34	56.24	20.85	63.88	27.44	Upgrade
Net Cash Flow	7.07	-20.72	15.1	-19.67	22.97	Upgrade
Free Cash Flow	-36.98	-52.13	-45.26	-78.98	-74.01	Upgrade
Free Cash Flow Margin	-	-22089.83%	-945.97%	-	-	Upgrade
Free Cash Flow Per Share	-2.50	-5.49	-8.11	-15.53	-16.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).